The past and future of ‘reported outcomes’ in studies on chemotherapy neuropathy

Por Beutler, A S, Majithia, N, Loprinzi, C L
Publicado no Ann Oncol (2017)

Hematology /

Por Williams, W. J., Beutler, A., Erslev, A. J.
Publicado em 1972

Gender differences in the incidence and prevalence of patellofemoral pain syndrome

Por Boling, M., Padua, D., Marshall, S., Guskiewicz, K., Pyne, S., Beutler, A.
Publicado em 2010

Serum uric acid in acute gout

Por SCHLESINGER, N., JR, H, BEUTLER;, A., MCGILL, P., LOGAN, J., MORRISON, E.
Publicado em 1998

Infliximab improves health related quality of life and physical function in patients with psoriatic arthritis

Por Kavanaugh, A, Antoni, C, Krueger, G G, Yan, S, Bala, M, Dooley, L T, Beutler, A, Guzzo, C, Gladman, D
Publicado em 2006

Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial

Por Antoni, C, Krueger, G, de Vlam, K, Birbara, C, Beutler, A, Guzzo, C, Zhou, B, Dooley, L, Kavanaugh, A, t for
Publicado em 2005

The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year

Por Kavanaugh, A, Antoni, C E, Gladman, D, Wassenberg, S, Zhou, B, Beutler, A, Keenan, G, Burmester, G, Furst, D E, Weisman, M H, Kalden, J R, Smolen, J, van der Heijde, D
Publicado em 2006

Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial

Por Kavanaugh, A, Krueger, G G, Beutler, A, Guzzo, C, Zhou, B, Dooley, L T, Mease, P J, Gladman, D D, de Vlam, K, Geusens, P P, Birbara, C, Halter, D G, Antoni, C
Publicado em 2007